What is ochronosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Ochronosis?

Ochronosis is a condition characterized by the abnormal deposition of dark pigment (typically brown, blue-gray, or blue-black) in connective tissues, most notably affecting cartilage, skin, and joints, occurring in two distinct forms: endogenous (alkaptonuria) and exogenous (typically from hydroquinone use).

Two Distinct Types

Endogenous Ochronosis (Alkaptonuria)

This is a rare autosomal recessive metabolic disorder caused by deficiency of homogentisic acid oxidase enzyme 1, 2. The enzyme deficiency leads to:

  • Accumulation of homogentisic acid (HGA) in tissues and increased urinary excretion
  • Dark urine that turns black upon standing or exposure to air (oxidation of HGA) 2, 3
  • Progressive pigment deposition in collagen-rich tissues over decades

Clinical manifestations typically appear after age 30 and include 4:

  • Blue-black pigmentation of ear cartilage and sclera (pathognomonic finding)
  • Bluish discoloration in axillary and inguinal areas
  • Degenerative arthropathy (ochronotic arthropathy) affecting spine and large joints
  • Cardiovascular involvement (aortic valve calcification, valvular disease) 3

Diagnostic approach:

  • Simplest screening: observe urine standing in light for 24 hours—it will darken 3
  • Confirmatory: elevated urinary homogentisic acid
  • Radiographic findings: extensive disc calcifications, vacuum disc phenomenon, osteophytic bridges 5

Exogenous Ochronosis

This is an acquired, iatrogenic condition resulting from prolonged topical use of hydroquinone-containing skin-lightening products 6, 7.

Key characteristics:

  • Can develop with as little as 3 months of 2% hydroquinone use 8
  • Duration and concentration are critical factors
  • Presents as periorbital, temporal, and facial hyperpigmentation 7
  • Histopathology shows: yellow-brown, round, sickle- or banana-shaped ochronotic bodies deposited between collagen bundles 7

Critical clinical pitfall: The diagnosis is frequently missed when relevant history of skin-lightening cream use is not obtained 7.

Pathophysiology

The process involves 1:

  • HGA (endogenous) or hydroquinone metabolites (exogenous) polymerize and oxidize
  • Pigment deposits selectively in connective tissues
  • Alters tissue properties leading to progressive failure
  • Cartilage is preferentially affected while liver and brain remain unaffected

Clinical Consequences

Ochronotic Arthropathy

This is the most debilitating manifestation 1, 9:

  • Resembles osteoarthritis but with younger age of onset
  • Preferentially affects 2nd and 3rd metacarpophalangeal joints, ankles, spine, and large joints 10
  • Characterized by exuberant osteophytes and rapid cartilage loss
  • Chondrocalcinosis present in 50% of cases 10
  • Does NOT respond to phlebotomy (distinguishing from hemochromatosis arthropathy) 10

Radiographic Features

  • Joint space narrowing
  • Osteophytes
  • Subchondral cysts
  • Extensive intervertebral disc calcifications 5, 4

Management Considerations

For endogenous ochronosis:

  • No curative treatment exists 2
  • Progressive and irreversible but life expectancy is preserved 2
  • Treatment limited to symptomatic relief: analgesics, NSAIDs, physiotherapy
  • Ultimately may require joint replacement 10

For exogenous ochronosis:

  • Immediate cessation of hydroquinone use is essential 6, 8
  • Cannot be fully reversed 1
  • Dermoscopy and clinicopathological correlation crucial for early detection 8

Important Clinical Caveats

  1. Hydroquinone-related concerns: Beyond ochronosis, hydroquinones can cause irritation, contact dermatitis, and there are ongoing debates about carcinogenicity 6

  2. Intraoperative discovery: Surgeons may encounter characteristic black discoloration of cartilage, tendons, and bone during procedures—this should prompt immediate investigation 4, 9

  3. Differential diagnosis: Must distinguish from hemochromatosis arthropathy (which has similar joint involvement but responds to phlebotomy) and seronegative spondyloarthropathies 4

  4. Earlier detection is desirable but challenging; noninvasive methods are needed 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.